Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82

[Pre-randomisation in study designs: getting past the taboo].

Nederlands tijdschrift voor geneeskunde·2008

[Granulomatous lobular mastitis: a benign abnormality that mimics malignancy].

Nederlands tijdschrift voor geneeskunde·2008

WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain.

The Cochrane database of systematic reviews·2007

Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.

BJOG : an international journal of obstetrics and gynaecology·2007

[The risk of cancer in inhabitants of Weurt, the Netherlands].

Nederlands tijdschrift voor geneeskunde·2004

Nationwide breast cancer screening programme fully implemented in The Netherlands.

Breast (Edinburgh, Scotland)·2004

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Perceived Barriers Among Midwives to Implementation of the Modified Partograph in a Public Hospital in Gauteng Province, South Africa.

Birth (Berkeley, Calif.)·2026

Office-hours versus off-hours deliveries among low-risk singleton pregnancies in Türkiye and early maternal and neonatal adverse outcomes: A retrospective cohort study.

Journal of neonatal-perinatal medicine·2026

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.

Breast (Edinburgh, Scotland)·2026

The association of a team management model based on Timing It Right theory with outcomes after cesarean section.

Medicine·2026

Identification of independent predictors of successful external cephalic version: A retrospective multicenter study.

Medicine·2026

Caregiver Satisfaction and Experience With a Novel Device to Safely Transport Life-Sustaining Durable Medical Equipment.

Dimensions of critical care nursing : DCCN·2026

Related Experiment Videos

Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82

Related Concept Videos

[Pre-randomisation in study designs: getting past the taboo].

[Granulomatous lobular mastitis: a benign abnormality that mimics malignancy].

WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain.

Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.

[The risk of cancer in inhabitants of Weurt, the Netherlands].

Nationwide breast cancer screening programme fully implemented in The Netherlands.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Perceived Barriers Among Midwives to Implementation of the Modified Partograph in a Public Hospital in Gauteng Province, South Africa.

Office-hours versus off-hours deliveries among low-risk singleton pregnancies in Türkiye and early maternal and neonatal adverse outcomes: A retrospective cohort study.

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.

The association of a team management model based on Timing It Right theory with outcomes after cesarean section.

Identification of independent predictors of successful external cephalic version: A retrospective multicenter study.

Caregiver Satisfaction and Experience With a Novel Device to Safely Transport Life-Sustaining Durable Medical Equipment.

Related Experiment Videos

Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82

Related Concept Videos

Related Articles